← SynDRA
AZELIRAGON
SynDRA canonical compound SYN0039156 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | AGER |
|---|
| Mechanism of action | RAGE receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- AGER ANTAGONIST
- Advanced glycosylation end product-specific receptor antagonist
- RAGE receptor antagonist
Cross-references
Synonyms
- PF-04494700
- TTP-488
- TTP448
- TTP488
- PF-4494700
- TTP-488)
- Alzheimers therapy, TransTech/Pfizer
- Diabetic nephropathy therapy, Transtech/Pfizer
- Alzheimer'streatment, TransTech/Pfizer
- Alzheimer's therapy (RAGE), Transtech/Pfizer
- LPU25F15UQ
- azeliragonum
- RefChem:560475
- DTXCID601549037
- Azeliragon [INN]
- Azeliragon free base
- Azeliragon [USAN]
- TTP488;PF-04494700
- MFCD11977600
- UNII-LPU25F15UQ
- Azeliragon (TTP488)
- Azeliragon (USAN/INN)
- Azeliragon [USAN:INN]
- AZELIRAGON [WHO-DD]
- C32H38ClN3O2
- GTPL8317
- orb1305379
- SCHEMBL1142599
- GLXC-90325
- EX-A1834
- BDBM50249580
- s6415
- AKOS026750516
- AzeliragonPF-04494700,TTP488
- CS-5117
- SB19818
- AzeliragonPF-04494700,TTP488?
- AC-35831
- AS-49837
Look up AZELIRAGON in the interactive SynDRA portal →